India's Drug Exporters Await Court Ruling On New Bar-Code Requirement
This article was originally published in PharmAsia News
India's drug exporters, who face a year-end deadline for adding bar-codes to their packaging, await a possible Madras High Court decision before then on a challenge to the edict intended to provide a traceable system to detect fake "Made In India" drugs actually made in China.
You may also be interested in...
The Italian firm has some talking to do with the US FDA before it can unblind Phase III data on sarizotan, its Rett syndrome therapy which could be "potentially transformative" for Newron.
No device-related warning letters were released by the US FDA the week of 10 December.
Immuno-oncology development trends are revealed through an analysis of deals between cancer drug developers over the past five years.